453
Views
0
CrossRef citations to date
0
Altmetric
Retina and Choroid

Glycemic Variability and the Thickness of Retinal Layers in Cystic Fibrosis Patients with and without Cystic Fibrosis Related Diabetes

, , , , &
Pages 759-767 | Received 08 Aug 2023, Accepted 13 Mar 2024, Published online: 01 Apr 2024

References

  • Elborn JS. Cystic fibrosis. Lancet. 2016;388(10059):2519–2531. doi: 10.1016/S0140-6736(16)00576-6.
  • Ratjen F, Bell SC, Rowe SM, Goss CH, Quittner AL, Bush A. Cystic fibrosis. Nat Rev Dis Primers. 2015;1(1):15010. doi: 10.1038/nrdp.2015.10.
  • McBennett KA, Davis PB, Konstan MW. Increasing life expectancy in cystic fibrosis: advances and challenges. Pediatr Pulmonol. 2022;57(Suppl 1):S5–S12. doi: 10.1002/ppul.25733.
  • Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel PR, Tullis E, Castaños C, Castellani C, et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020;8(1):65–124. doi: 10.1016/S2213-2600(19)30337-6.
  • Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care. 2009;32(9):1626–1631. doi: 10.2337/dc09-0586.
  • Hameed S, Morton JR, Jaffé A, Field PI, Belessis Y, Yoong T, Katz T, Verge CF. Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain. Diabetes Care. 2010;33(2):221–226. doi: 10.2337/dc09-1492.
  • Lewis C, Blackman SM, Nelson A, Oberdorfer E, Wells D, Dunitz J, Thomas W, Moran A. Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex. Am J Respir Crit Care Med. 2015;191(2):194–200. doi: 10.1164/rccm.201403-0576OC.
  • Kayani K, Mohammed R, Mohiaddin H. Cystic fibrosis-related diabetes. Front Endocrinol. 2018;9:20. doi: 10.3389/fendo.2018.00020.
  • Ballmann M, Hubert D, Assael BM, Kronfeld K, Honer M, Holl RW, CFRD Study Group. Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus. BMC Pediatr. 2014;14(1):70. doi: 10.1186/1471-2431-14-70.
  • Ballmann M, Hubert D, Assael BM, Staab D, Hebestreit A, Naehrlich L, Nickolay T, Prinz N, Holl RW, CFRD Study Group. Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial. Lancet Diabetes Endocrinol. 2018;6(2):114–121. doi: 10.1016/S2213-8587(17)30400-X.
  • Yi Y, Norris AW, Wang K, Sun X, Uc A, Moran A, Engelhardt JF, Ode KL. Abnormal glucose tolerance in infants and young children with cystic fibrosis. Am J Respir Crit Care Med. 2016;194(8):974–980. doi: 10.1164/rccm.201512-2518OC.
  • Mackie AD, Thornton SJ, Edenborough FP. Cystic fibrosis-related diabetes. Diabet Med. 2003;20(6):425–436. doi: 10.1046/j.1464-5491.2003.00924.x.
  • Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med. 2000;162(3 Pt 1):891–895. doi: 10.1164/ajrccm.162.3.9904075.
  • Leclercq A, Gauthier B, Rosner V, Weiss L, Moreau F, Constantinescu AA, Kessler R, Kessler L. Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients. J Cyst Fibros. 2014;13(4):478–484. doi: 10.1016/j.jcf.2013.11.005.
  • Schiaffini R, Brufani C, Russo B, Fintini D, Migliaccio A, Pecorelli L, Bizzarri C, Lucidi V, Cappa M. Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system. Eur J Endocrinol. 2010;162(4):705–710. doi: 10.1530/EJE-09-1020.
  • Franzese A, Valerio G, Buono P, Spagnuolo MI, Sepe A, Mozzillo E, De Simone I, Raia V. Continuous glucose monitoring system in the screening of early glucose derangements in children and adolescents with cystic fibrosis. J Pediatr Endocrinol Metab. 2008;21(2):109–116. doi: 10.1515/jpem.2008.21.2.109.
  • Dobson L, Sheldon CD, Hattersley AT. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med. 2004;21(7):691–696. doi: 10.1111/j.1464-5491.2004.01219.x.
  • O’Riordan SMP, Hindmarsh P, Hill NR, Matthews DR, George S, Greally P, Canny G, Slattery D, Murphy N, Roche E, et al. Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study. Diabetes Care. 2009;32(6):1020–1022.,. doi: 10.2337/dc08-1925.
  • Chan CL, Vigers T, Pyle L, Zeitler PS, Sagel SD, Nadeau KJ. Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline. J Cyst Fibros. 2018;17(6):783–790. doi: 10.1016/j.jcf.2018.03.008.
  • Roberts R, Speight L, Lee J, George L, Ketchell RI, Lau D, Duckers J. Retinal screening of patients with cystic fibrosis-related diabetes in Wales – a real eye opener. J Cyst Fibros. 2015;14(2):282–284. doi: 10.1016/j.jcf.2014.07.014.
  • van den Berg JM, Morton AM, Kok SW, Pijl H, Conway SP, Heijerman HG. Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD). J Cyst Fibros. 2008;7(6):515–519. doi: 10.1016/j.jcf.2008.05.008.
  • Nebbioso M, Quattrucci S, Leggieri E, Spadea L, Vingolo EM. Cystic fibrosis and new trends by ophthalmological evaluation: a pilot study. Biomed Res Int. 2014;2014:580373–580375. doi: 10.1155/2014/580373.
  • Kempegowda P, Sunsoa H, Chandan JS, Quinn LM, Amrelia PM, Atta SN, Amir S, Teh YS, Chaudhry S, de Bray A, et al. Retinopathy and microalbuminuria are common microvascular complications in cystic fibrosis-related diabetes. Ther Adv Endocrinol Metab. 2020;11:2042018820966428. doi: 10.1177/2042018820966428.
  • Schwarzenberg SJ, Thomas W, Olsen TW, Grover T, Walk D, Milla C, Moran A. Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care. 2007;30(5):1056–1061. doi: 10.2337/dc06-1576.
  • Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiøtz PO, Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr. 1994;83(1):72–77. doi: 10.1111/j.1651-2227.1994.tb12956.x.
  • Rodman HM, Doershuk CF, Roland JM. The interaction of 2 diseases: diabetes mellitus and cystic fibrosis. Medicine. 1986;65(6):389–397. doi: 10.1097/00005792-198611000-00004.
  • Rosenecker J, Höfler R, Steinkamp G, Eichler I, Smaczny C, Ballmann M, Posselt HG, Bargon J, von der Hardt H. Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome. Eur J Med Res. 2001;6(8):345–350.
  • Scott AI, Clarke BE, Healy H, DE M, Bell SC. Microvascular complications in cystic fibrosis-related diabetes mellitus: a case report. JOP. 2000;1:208–210.
  • Sullivan MM, Denning CR. Diabetic microangiopathy in patients with cystic fibrosis. Pediatrics. 1989;84(4):642–647.
  • O’Riordan JI, Hayes J, Fitzgerald MX, Redmond J. Peripheral nerve dysfunction in adult patients with cystic fibrosis. Ir J Med Sci. 1995;164(3):207–208. doi: 10.1007/BF02967830.
  • Chakrabarty B, Kabra SK, Gulati S, Toteja GS, Lodha R, Kabra M, Pandey RM, Srivastava A. Peripheral neuropathy in cystic fibrosis: a prevalence study. J Cyst Fibros. 2013;12(6):754–760. doi: 10.1016/j.jcf.2013.01.005.
  • El-Salem K, Aburahma S, Rawashdeh M. Peripheral nerve dysfunction in patients with cystic fibrosis. J Clin Neurophysiol. 2010;27(3):216–218. doi: 10.1097/01.WNP.0b013e3181e0a9f9.
  • Prakasam RK, Götze A, von Keyserlingk S, Jünemann A, Röhlig M, Stachs O, Fischer DC. Spectral-domain optical coherence tomography for determination of retinal thickness in pediatric patients with mild-to-moderate chronic kidney disease: a cross-sectional study. Curr Eye Res. 2019;44(2):206–211. doi: 10.1080/02713683.2018.1522649.
  • Prakasam RK, Matuszewska-Iwanicka A, Fischer DC, Schumann H, Tschöpe D, Stratmann B, Hettlich HJ, Guthoff RF, Stachs O, Röhlig M. Thickness of intraretinal layers in patients with type 2 diabetes mellitus depending on a concomitant diabetic neuropathy: results of a cross-sectional study using deviation maps for OCT data analysis. Biomedicines. 2020;8(7):190. doi: 10.3390/biomedicines8070190.
  • Götze A, von Keyserlingk S, Peschel S, Jacoby U, Schreiver C, Köhler B, Allgeier S, Winter K, Röhlig M, Jünemann A, et al. The corneal subbasal nerve plexus and thickness of the retinal layers in pediatric type 1 diabetes and matched controls. Sci Rep. 2018;8(1):14. doi: 10.1038/s41598-017-18284-z.
  • Prakasam RK, Röhlig M, Fischer DC, Götze A, Jünemann A, Schumann H, Stachs O. Deviation maps for understanding thickness changes of inner retinal layers in children with type 1 diabetes mellitus. Curr Eye Res. 2019;44(7):746–752. doi: 10.1080/02713683.2019.1591463.
  • Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geiß HC, Hesse V, von Hippel A, Jaeger U, Johnsen D, Korte W, et al. Perzentile für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd. 2001;149(8):807–818. doi: 10.1007/s001120170107.
  • Neuhauser HK, Thamm M, Ellert U, Hense HW, Rosario AS. Blood pressure percentiles by age and height from nonoverweight children and adolescents in Germany. Pediatrics. 2011;127(4):e978-88–e988. doi: 10.1542/peds.2010-1290.
  • Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. doi: 10.1183/09031936.00080312.
  • Moran A, Pillay K, Becker D, Granados A, Hameed S, Acerini CL. ISPAD clinical practice consensus guidelines 2018: management of cystic fibrosis-related diabetes in children and adolescents. Pediatr Diabetes. 2018;19(Suppl 27):64–74. doi: 10.1111/pedi.12732.
  • Schreiver C, Jacoby U, Watzer B, Thomas A, Haffner D, Fischer DC. Glycaemic variability in paediatric patients with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI): a cross-sectional cohort study. Clin Endocrinol. 2013;79(5):641–647. doi: 10.1111/cen.12093.
  • Ní Dhubhghaill S, Rozema JJ, Jongenelen S, Ruiz Hidalgo I, Zakaria N, Tassignon MJ. Normative values for corneal densitometry analysis by Scheimpflug optical assessment. Invest Ophthalmol Vis Sci. 2014;55(1):162–168. doi: 10.1167/iovs.13-13236.
  • Cahn F, Burd J, Ignotz K, Mishra S. Measurement of lens autofluorescence can distinguish subjects with diabetes from those without. J Diabetes Sci Technol. 2014;8(1):43–49. doi: 10.1177/1932296813516955.
  • Early Treat Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs–an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991;98:786–806.
  • Röhlig M, Schmidt C, Prakasam RK, Rosenthal P, Schumann H, Stachs O. Visual analysis of retinal changes with optical coherence tomography. Vis Comput. 2018;34(9):1209–1224. doi: 10.1007/s00371-018-1486-x.
  • Röhlig M, Prakasam RK, Stüwe J, Schmidt C, Stachs O, Schumann H. Enhanced grid-based visual analysis of retinal layer thickness with optical coherence tomography. Information. 2019;10(9):266. doi: 10.3390/info10090266.
  • Andersen HU, Lanng S, Pressler T, Laugesen CS, Mathiesen ER. Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications. Diabetes Care. 2006;29(12):2660–2663. doi: 10.2337/dc06-0654.
  • Yung B, Landers A, Mathalone B, Gyi KM, Hodson ME. Diabetic retinopathy in adult patients with cystic fibrosis-related diabetes. Respir Med. 1998;92(6):871–872. doi: 10.1016/s0954-6111(98)90390-0.